首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
On October 2nd, Ashoka Mukpo left his father a voice mail from Monrovia, saying he had "unwelcome but not unexpected news. " Muk
On October 2nd, Ashoka Mukpo left his father a voice mail from Monrovia, saying he had "unwelcome but not unexpected news. " Muk
admin
2019-07-19
53
问题
On October 2nd, Ashoka Mukpo left his father a voice mail from Monrovia, saying he had "unwelcome but not unexpected news. " Mukpo, an American freelance camera-man for NBC News, had tested positive for Ebola virus. Mukpo’s father, Mitchell Levy, a pulmonologist who heads critical care at Rhode Island Hospital in Providence, immediately helped arrange his son’s transfer to the Nebraska Medical Center in Omaha, one of the four specialized Ebola centres in the United States.
The big question then was how to treat the patient.
The medical team, which included Levy, planned to intensively monitor Mukpo and give him intravenous replacement of fluids and electrolytes, antibiotics to combat also had three unproven treatments available. TKM-Ebola, which inhibits viral RNA, has worked beautifully in monkeys, the best animal model. Kent Brantly, a missionary doctor in Liberia who developed Ebola and recovered, offered to donate plasma removed from his blood, which contained antibodies that might help. And there was brincidofovir, a drug being developed for other viral infections that has been shown to stop Ebola virus in test tubes. The most famous drug candidate, ZMapp, was not available at the time. After careful consideration, Mukpo and his doctors opted to use the serum—a proven intervention with other viruses—and brincidofovir, which has a substantial safety record. But they decided to forgo TKM-Ebola, despite its promise, because of worries that it could trigger overproduction of cytokines, a dangerous inflammatory response also caused by the Ebola virus, and scant data from human trials. "I was not quite on my deathbed and didn’t need to take any huge risks," Mukpo says. His doctor father had reached a similar conclusion. "I didn’t have a high degree of confidence that brincidofovir was going to work, but I was loath to try an investigational agent with no data," Levy says.
Mukpo survived, but no one has any idea whether the experimental treatments helped him, did nothing, or even slowed his recovery. The same is true for Brandy and 17 other Ebola patients who received experimental interventions in the United States and Europe.(One other Ebola patient was treated in Germany without any experimental interventions.)Many, like Mukpo, were given several treatments at the same time, making it hard to unravel the impact of anyone of them. The fact that they were taken care of in modern, well-staffed hospitals may also help explain why 75 % have survived. "Probably the best we can say is that the experimental treatments are not killing anyone," says Michael Kurllla, who heads the Office of Biodefense Research Resources and Translational Research at the National Institute of Allergy and Infectious Diseases(NIAID)in Roekville, Maryland.
Now, that’s about to change. As early as next month, researchers will begin trials in West Africa to find a solid answer to the key question: Do the treatments work? Carried out in makeshift e-mergency hospitals by researchers wearing full protective gear in the middle of a deadly epidemic, these will be some of the most unusual drug trials ever done. And they also raise major ethical and practical questions, some of which were intensely debated at a World Health Organization(WHO)meeting in Geneva, Switzerland, on November 11th and 12th. Perhaps the most important one: Is it right to do randomized controlled trials(RCTs), in which some people don’t get the novel intervention ? Doctors without Borders(MSF), which has led the medical response to the outbreak, says no—not with a disease as deadly as Ebola. Instead, on November 13th MSF said it will take part in three trials that will use an alternative design in which everyone who enrolls receives the untested treatment. But others argue that such setups may not give clear answers and squander a precious scientific opportunity.
It’s an uncomfortable and complex debate held under extreme time pressure. " Everyone has stepped outside of their comfort zone in a big way," says Peter Horby of the University of Oxford in the United Kingdom, who is leading one of the upcoming trials and attended the WHO meeting.
Questions 66 to 70
Answer the following questions with the information given in the passage.
What is the objective of the trials conducted in West Africa?
选项
答案
To find out whether the treatment works.
解析
(答案在文中明确给出,参见第五段第二句“To find a solid answer to the key question:Dothe treatments work?”。)
转载请注明原文地址:https://kaotiyun.com/show/mQfK777K
本试题收录于:
A类竞赛(研究生)题库大学生英语竞赛(NECCS)分类
0
A类竞赛(研究生)
大学生英语竞赛(NECCS)
相关试题推荐
Themajorpartofmychildhoodwasspentinfightingoffterrorofthingswhichdidn’texist,andIdon’tthinkmyfatherever
Themajorpartofmychildhoodwasspentinfightingoffterrorofthingswhichdidn’texist,andIdon’tthinkmyfatherever
Themajorpartofmychildhoodwasspentinfightingoffterrorofthingswhichdidn’texist,andIdon’tthinkmyfatherever
Themajorpartofmychildhoodwasspentinfightingoffterrorofthingswhichdidn’texist,andIdon’tthinkmyfatherever
WhenIwasateenager,I______alotandpeoplecouldn’tunderstandwhatIwassaying.
Writeonthefollowingtopic.MarkTwainoncesaid,"WhenIwasfourteenyearsold,Iwasamazedathowunintelligentmyfather
WhowasafoundingfatheroftheAmericanRepublic?
MyentryintoBlackwomen’shistorywasunexpectedbutagreeable.IntheprefacetoBlackWomeninAmerica:AnHistoricalEncycl
随机试题
在心动周期中,心室充盈主要依靠
患者,28岁,女性,产后第26天,主诉畏寒发热伴右乳疼痛3天,查右乳局部皮肤红肿痛,局部皮肤表面有脱屑,腋窝淋巴结肿大,压痛,问患者可能的诊断是
下列哪项不是珍珠母的功效
对于卧式或立式离心泵、混流泵机组,当进水池水位(或水源水位)变幅大于H效吸,且泵房地基承载力较低或地下水位较高时可建()。
某国游客在中国旅游期间自然死亡,按有关规定,若死者家属或()要求解剖,我方可同意,但必须有他们签字的书面请求。
受教育权是儿童享有的一项基本权利,是一项合法权利。()
下列选项中,属于法治应当遵循的基本原则的有()。
=________.
在如下基于网络入侵检测系统的基本结构图中,对应I、Ⅱ、Ⅲ模块的名称是——。
采用IEEE802.11b标准将两栋楼的局域网互连为一个逻辑网络,应使用的无线设备是
最新回复
(
0
)